These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18710882)

  • 21. Ab initio identification of putative human transcription factor binding sites by comparative genomics.
    Corà D; Herrmann C; Dieterich C; Di Cunto F; Provero P; Caselle M
    BMC Bioinformatics; 2005 May; 6():110. PubMed ID: 15865625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MVisAGe Identifies Concordant and Discordant Genomic Alterations of Driver Genes in Squamous Tumors.
    Walter V; Du Y; Danilova L; Hayward MC; Hayes DN
    Cancer Res; 2018 Jun; 78(12):3375-3385. PubMed ID: 29700001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global risk transformative prioritization for prostate cancer candidate genes in molecular networks.
    Chen L; Tai J; Zhang L; Shang Y; Li X; Qu X; Li W; Miao Z; Jia X; Wang H; Li W; He W
    Mol Biosyst; 2011 Sep; 7(9):2547-53. PubMed ID: 21735017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma.
    Corson TW; Gallie BL
    Genes Chromosomes Cancer; 2007 Jul; 46(7):617-34. PubMed ID: 17437278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pinpointing disease genes through phenomic and genomic data fusion.
    Jiang R; Wu M; Li L
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S3. PubMed ID: 25708473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenes expand during evolution to withstand somatic amplification.
    Wang X; Li X; Zhang L; Wong SH; Wang MHT; Tse G; Dai RZW; Nakatsu G; Coker OO; Chen Z; Ko H; Chan JYK; Liu T; Cheng CHK; Cheng ASL; To KF; Plewczynski D; Sung JJY; Yu J; Gin T; Chan MTV; Wu WKK
    Ann Oncol; 2018 Nov; 29(11):2254-2260. PubMed ID: 30204835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Identification of oncogenes and anti-oncogenes].
    Thomas G
    Pathol Biol (Paris); 1995 Mar; 43(3):143-9. PubMed ID: 7675540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative oncogenomic analysis of microarray data in hematologic malignancies.
    Martínez-Climent JA; Fontan L; Fresquet V; Robles E; Ortiz M; Rubio A
    Methods Mol Biol; 2010; 576():231-77. PubMed ID: 19882266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Zhuang S; Söderkvist P
    Mutat Res; 2000 Jul; 452(1):19-26. PubMed ID: 10894886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular biology of proto-oncogenes in genitourinary cancers.
    Peehl DM
    Cancer; 1987 Aug; 60(3 Suppl):645-9. PubMed ID: 3594397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular biology of lung cancer.
    Ross JA; Rosen GD
    Curr Opin Pulm Med; 2002 Jul; 8(4):265-9. PubMed ID: 12055387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
    Li Y; Sahni N; Yi S
    Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies.
    Jiang P; Lee W; Li X; Johnson C; Liu JS; Brown M; Aster JC; Liu XS
    Cell Syst; 2018 Mar; 6(3):343-354.e5. PubMed ID: 29428415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of oncogenesis.
    Turcanu V
    Rev Med Chir Soc Med Nat Iasi; 1992; 96 Suppl():13-8. PubMed ID: 1305322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
    Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
    Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.
    Kim A; Lim SM; Kim JH; Seo JS
    Front Immunol; 2021; 12():598671. PubMed ID: 33717076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational identification of cellular networks and pathways.
    Markowetz F; Troyanskaya OG
    Mol Biosyst; 2007 Jul; 3(7):478-82. PubMed ID: 17579773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KatzDriver: A network based method to cancer causal genes discovery in gene regulatory network.
    Akhavan-Safar M; Teimourpour B
    Biosystems; 2021 Mar; 201():104326. PubMed ID: 33309969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated oncogenes and putative tumor suppressor genes involved in human breast cancers.
    Tripathy D; Benz CC
    Cancer Treat Res; 1992; 63():15-60. PubMed ID: 1363356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of nucleosome positioning landscapes enables gene discovery in the human malaria parasite Plasmodium falciparum.
    Lu XM; Bunnik EM; Pokhriyal N; Nasseri S; Lonardi S; Le Roch KG
    BMC Genomics; 2015 Nov; 16():1005. PubMed ID: 26607328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.